Drug Trial Radar · NCT06055959
A Study to Evaluate Subcutaneous Zilucoplan in Pediatric Participants With Generalized Myasthenia Gravis
Last checked: Nov 19, 2026Latest source record: Nov 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
8
Planned (sponsor's estimate)
Start
Oct 16, 2024
Primary completion
May 12, 2027
Study completion Jun 22, 2027
Sponsor
- Lead sponsor
- UCB Biopharma SRLUCB
- Sponsor type
- Industry
- First posted
- Sep 28, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the pharmacokinetics, pharmacodynamics, safety, tolerability, immunogenicity and activity of zilucoplan (ZLP) in pediatric study participants with generalized myasthenia gravis (gMG).
Conditions
- Generalized Myasthenia Gravis
Interventions
ZilucoplanDrug
Zilucoplan will be administered subcutaneously to pediatric study participants.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Plasma concentrations of zilucoplan (ZLP) sampled at Week 4 (Day 29)Time frame: Week 4 (Day 29)
- Change from Baseline in sheep red blood cell (sRBC) lysis at Week 4 (Day 29)Time frame: Week 4 (Day 29)
- Change from Baseline in complement component 5 (C5) levels at Week 4 (Day 29)Time frame: Week 4 (Day 29)
Locations
9 sites in 5 countries. Site status is shown where the registry gives one.
Mg0014 50168
Chicago, Illinois · Withdrawn
Mg0014 50574
Denton, Texas · Withdrawn
Mg0014 40144
Milan, Italy · Recruiting
Mg0014 40774
Katowice, Poland · Recruiting
Mg0014 40218
Warsaw, Poland · Active not recruiting
Mg0014 20104
Seoul, South Korea · Withdrawn
Mg0014 20220
Seoul, South Korea · Recruiting
Mg0014 40735
Glasgow, United Kingdom · Recruiting
Mg0014 40736
London, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.